Orthofix awards options and stock to executive

Orthofix Medical Inc. executive Aviva McPherron, President of Global Operations & Quality, received equity awards on the form’s grant date.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Orthofix Medical Inc. executive Aviva McPherron, President of Global Operations & Quality, received equity awards on the form’s grant date. She was granted 54,656 stock options with an exercise right and 23,024 shares of common stock in the form of restricted stock units, both at a stated price of $0.00 per share.

The options and restricted stock units each vest in three equal one-third installments on the first, second, and third anniversaries of the grant date. After these awards, she directly holds 70,412 shares of common stock, which includes 37,557 previously reported restricted stock units and 1,066 shares acquired under Orthofix’s Stock Purchase Plan.

Insider Trade Summary

Grant/Award: 77,680 shares

Grant/Award 2 txns

Insider McPherron Aviva

Role Pres, Global Ops & Qual

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	54,656	$0.00	$0.00
Grant/Award	Common Stock	23,024	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (Right to Buy) — 54,656 contracts (Direct); Common Stock — 70,412 shares (Direct)

Footnotes (3)

F1. Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date.
F2. Includes 37,557 previously reported restricted stock units and 1,066 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
F3. The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

FAQ

What insider transaction was reported for Orthofix Medical (OFIX)?

Aviva McPherron reported equity awards from Orthofix Medical. She received 54,656 employee stock options and 23,024 shares of common stock as restricted stock units, with all awards granted at a stated price of $0.00 per share according to the Form 4 filing.

Who is Aviva McPherron in the Orthofix Medical (OFIX) Form 4 filing?

Aviva McPherron is identified as Orthofix Medical’s President, Global Operations & Quality. The Form 4 shows she received grants of stock options and restricted stock units, increasing her directly held common stock position to 70,412 shares following the reported transactions.

How many stock options did Aviva McPherron receive from Orthofix (OFIX)?

She was granted 54,656 employee stock options. The filing states these options vest and become exercisable in three equal one-third installments on the first, second, and third anniversaries of the grant date, aligning her potential equity benefits with a multi-year timeframe.

What restricted stock unit award did Orthofix Medical (OFIX) grant to Aviva McPherron?

She received 23,024 shares of common stock in the form of restricted stock units. These restricted stock units vest in three equal one-third tranches on each of the first, second, and third anniversaries of the grant date, as approved by the board committee.

How many Orthofix Medical (OFIX) shares does Aviva McPherron hold after the grant?

After the reported grant, she directly holds 70,412 shares of common stock. This figure includes 37,557 previously reported restricted stock units and 1,066 shares acquired under Orthofix’s Stock Purchase Plan, as described in the Form 4 footnotes.

How do Aviva McPherron’s Orthofix (OFIX) awards vest over time?

Both the stock options and restricted stock units vest over three years. One-third of the underlying shares vests on each of the first, second, and third anniversaries of the grant date, creating a structured, multi-year vesting schedule tied to continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/05/2026 - 06:51 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McPherron Aviva

(Last)

(First)

(Middle)

3451 PLANO PARKWAY

(Street)

LEWISVILLE

75056

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Pres, Global Ops & Qual

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/03/2026		A		23,024⁽¹⁾	A	$0	70,412⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$13.03	03/03/2026		A		54,656		⁽³⁾	03/03/2033	Common Stock	54,656	$0	54,656	D

Explanation of Responses:

1. Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date.

2. Includes 37,557 previously reported restricted stock units and 1,066 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

3. The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

	/s/ J. Andres Cedron, attorney-in-fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR